Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.The State Council Taiwan Affairs Office: Welcome Mr. Ma Ying-jeou to lead a delegation to visit again. On the 11th, Zhu Fenglian, a spokesman for the Taiwan Affairs Office of, introduced at a regular press conference that Mr. Ma Ying-jeou will lead Taiwan Province youth to attend and visit the Youth Ice and Snow Festival on both sides of the Taiwan Strait in Heilongjiang and Sichuan from December 18 to 26. We welcome Mr. Ma Ying-jeou to lead a delegation to visit again and will make arrangements for various activities. (Xinhua News Agency)Head of South Korea's senior public official crime investigation department: If the conditions are met, it will seek to arrest Yin Xiyue. The head of South Korea's senior public official crime investigation department said that if the conditions are met, the team will seek to arrest President Yin Xiyue or seek to issue an arrest warrant for him. On Wednesday, when answering questions raised by opposition lawmakers at the National Assembly meeting, Oh Dong-woon indicated that he had the intention to arrest Yin Xiyue.
Private placement: Positive factors in the stock market are accumulating. Recently, A-shares have fluctuated, and the latest strategies of many first-line private placements for investment at the end of the year and the beginning of the year have been released one after another. A number of private placements are optimistic about the market at the end of the year. Kou Zhiwei, a partner of chongyang investment, said that the "strengthening unconventional countercyclical adjustment" proposed by the policy at the end of the year inspired market confidence. At present, compared with the end of September, the market has a large increase, and the market has fully expected and priced the policy overweight. The further rise of the short-term market may need the support of strong economic recovery data. Judging from the recent overall investment trends of private placement, the reporter found that maintaining medium and high positions and maintaining high flexibility of portfolios have become the strategic focus of current private placement institutions. (CSI)Citigroup: By 2025, the average price of LNG in Europe TTF and Asia JKM may reach 12.9 USD/million british thermal unit and 13.2 USD/million british thermal unit respectively.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
India's SENSEX30 index opened 0.07% higher at 81,568.39 points. Among the constituent stocks, ULTRATECH CEMENT opened 1% higher, Asian Coatings rose 0.74% and BAJAJ FINANCE rose 0.62%. In terms of decline, Mahengda Information Technology opened 0.44% lower, India Industrial Credit Investment Bank fell 0.33%, and HCL TECHNOLOGIES fell 0.26%.Boeing also exposed nearly 1,000 layoffs. According to Xinhua News Agency, citing American media reports, American aircraft manufacturer Boeing will lay off employees again, involving nearly 1,000 people in Washington State and California. This batch of layoffs is part of Boeing's plan to lay off 17,000 people worldwide announced in October.Treasury futures closed in early trading, with the main contract of 2-year Treasury futures (TS) falling by 0.06%, 5-year Treasury futures (TF) falling by 0.13%, 10-year Treasury futures (T) falling by 0.15% and 30-year Treasury futures (TL) falling by 0.26%.
Strategy guide
12-13
Strategy guide 12-13